Name | Value |
---|---|
Revenues | 2,000.0M |
Cost of Revenue | 588.0M |
Gross Profit | 1,412.0M |
Operating Expense | 684.0M |
Operating I/L | 781.0M |
Other Income/Expense | -68.0M |
Interest Income | 33.0M |
Pretax | 697.0M |
Income Tax Expense | 146.0M |
Net Income/Loss | 552.0M |
Zoetis Inc. is a global leader in animal health, specializing in the discovery, development, manufacturing, and commercialization of medicines, vaccines, and diagnostic products for livestock and companion animals. The company's product portfolio includes vaccines, anti-infectives, parasiticides, pharmaceuticals, dermatology products, and medicated feed additives. Additionally, Zoetis provides portable blood and urine analysis testing, point-of-care diagnostic products, and other non-pharmaceutical products such as nutritionals and agribusiness services. Its primary revenue streams come from selling these products to veterinarians, livestock producers, retail outlets, and third-party veterinary distributors through its sales representatives and technical specialists.